Peter Day is currently serving as the CMC Program Leader at Denali Therapeutics since September 2024. Previously, Peter Day has held various positions at Genentech from July 2009, including Portfolio Leader, Director, Senior Scientist, Scientist, and Associate Scientist. Prior to that, Peter Day was a Postdoctoral Fellow at Stanford University Medical Center from August 2004 to September 2009. Peter Day earned a PhD in Molecular Pharmacology from Jefferson Health, completing the program in 2004.
This person is not in the org chart
This person is not in any teams
This person is not in any offices